Techno Trends
TechnoTrends provide comprehensive coverage of the innovations and inventions in pharma products and pharma technologies across the world. The up-to-date listing of latest pharmaceutical product news and technology trends in the global pharma industry, keeps you abreast with all the latest pharmaceutical innovations happening world over.
Duke-NUS Medical School Discovered Breakthrough Treatment for Neurodevelopmental Disorders
Researchers at Duke-NUS Medical School and the Mechanobiology Institute (MBI) at the National University of Singapore (NUS) have uncovered a novel pathway that can awaken dormant neural stem cells, paving the way for potential new therapies for neurodevelopmental disorders such...
Novartis Discovered First-of-its-Kind Fabhalta (iptacopan) Immunoglobulin A Nephropathy
Novartis has introduced Fabhalta (iptacopan), a first-of-its-kind treatment designed to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk of rapid disease progression. Fabhalta specifically targets the alternative complement pathway...
Attralus Introduces First 124I-evuzamitide (AT-01) for Cardiac Amyloidosis
Attralus has introduced 124I-evuzamitide (AT-01), the first pan-amyloid diagnostic PET imaging candidate designed for cardiac amyloidosis. Recognised for its potential as a groundbreaking diagnostic tool, 124I-evuzamitide...
Adaptimmune Therapeutics Introduces Breakthrough TECELRA® Cell Therapy for Solid Tumor
Adaptimmune Therapeutics has unveiled TECELRA® (afamitresgene autoleucel), a groundbreaking treatment for adults with unresectable or metastatic synovial sarcoma who have previously undergone chemotherapy. TECELRA® (afamitresgene autoleucel) is a genetically modified autologous T cell immunotherapy...
Indiana University Unveils Ground Breaking New Gene Therapy for Duchenne Muscular Systrophy
Indiana University has introduced a groundbreaking gene therapy technique that restores the full-length dystrophin protein, potentially leading to new treatments for Duchenne muscular dystrophy...
AusperBio Therapeutics Introduces Novel AHB-137 for Chronic Hepatitis B Treatment
AusperBio Therapeutics has introduced AHB-137, a groundbreaking treatment for chronic hepatitis B (CHB). With approximately 296 million people globally affected by chronic HBV and limited treatment options for a cure, the disease...
Sanofi Unveils Ground breaking Dupixent Therapy for Chronic Obstructive Pulmonary Disease
Sanofi has introduced Dupixent, a groundbreaking addition to maintenance therapy for adults suffering from uncontrolled chronic obstructive pulmonary disease characterised by elevated blood...
Eli Lilly Introduced First-of-its-kind Kisunla™ for Alzheimer's Disease
Eli Lilly has launched Kisunla™, a groundbreaking therapy for adults with early symptomatic Alzheimer's disease, encompassing those with mild cognitive impairment...
Ligand Pharmaceuticals Develops Novel Ohtuvayre™ for the Treatment of Chronic Obstructive Pulmonary Disease
Ligand Pharmaceuticals has developed Ohtuvayre™, the first inhaled treatment with a novel mechanism for chronic obstructive pulmonary disease in over 20 years....
Aurion Biotech Developed Novel Drug Candidate AURN001
Aurion Biotech has introduced AURN001, a novel treatment developed for addressing corneal oedema resulting from corneal endothelial disease....
